Pay in 4 interest-free payments of $42.50 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
as well as induces cell cycle arrest at the G2/M phase and apoptosis in
The cytotoxic effect of VPC-14337 on cardiac fibroblasts specifically under glucose- and glutamine-deficient condition
Fenretinide (4-HPR) (10 mg/kg
acetyl-transferase protein NAT10 was identified as the target of Remodelin that mediated nuclear shape rescue in laminopathic cells via microtubule reorganization
A-836339 60106 as well as induces cellA 836339 is a drug developed by Abbott Laboratories that acts as a potent cannabinoid receptor full agonist. It is selective for CB2, with Ki values of 0. 64 nM at CB2 vs 270 nM at the psychoactive CB1 receptor, but while it exhibits selective analgesic, anti inflammatory and anti hyperalgesic effects at low doses, its high efficacy at both targets results in typical cannabis like effects appearing at higher doses, despite its low binding affinity for
US$ 197.00
US$ 209.00
US$ 103.40
US$ 199.50
US$ 128.50
US$ 459.50
US$ 160.00